October 01, 2025

Remibrutinib Gains FDA Nod for Urticaria

First oral BTK inhibitor approved for antihistamine-resistant chronic spontaneous urticaria, targeting mast cell–driven immune dysregulation

Conexiant

September 19, 2025

Anrikefon Reduced Itch in Patients on Hemodialysis

Adverse events with anrikefon were comparable to placebo in patients on hemodialysis.

Conexiant

September 18, 2025

Psoriasis Linked to Macular Degeneration

 Vision-threatening eye disease more common in psoriasis patients, but biologic therapy appears protective.

Conexiant

September 16, 2025

Lebrikizumab 24-Week Trial in Skin of Color Atopic Dermatitis

Lebrikizumab shows sustained efficacy across Fitzpatrick IV–VI at 24 weeks in atopic dermatitis.

Conexiant

September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 12, 2025

Maternal Health and Vitiligo: First Scoping Review Protocol

Protocol outlines review of vitiligo pregnancy outcomes, methods, and planned data mapping.

Conexiant

September 12, 2025

Dual-Mode Optical System Sharpens Skin Cancer Diagnosis

AI-assisted imaging merges structure and chemistry for noninvasive classification of nonmelanoma cancers

The Analytical Scientist

September 09, 2025

Top 10 States to Practice Dermatology

The following list highlights the states that offer the most favorable conditions for dermatologists.

Conexiant

April 01, 2018

Surgical Indications for Nonrhegmatogenous Retinal Detachment

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Retinal Physician